Skip to main content
Caplight Logo









AMI Pharm Co., Ltd.

AMI Pharm Co., Ltd.

Private
South KoreaHealthcare & Life Scienceshttp://amipharm.com/

Last Round

Private Equity

Sep 9, 2026

Total Funding Raised

$38M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AMI Pharm Co., Ltd. is a pharmaceutical company that develops injectable treatments for localized fat reduction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

medical aestheticsfat reductioninjectable drugbody contouringfat dissolvingbiotechnologysubmental fatnon-surgicalclinical trialsdrug developmentlipolysisaesthetic medicinek-biotechpharmaceutical r&d

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMI Pharm Co., Ltd. Comparables

Compare AMI Pharm Co., Ltd. with similar companies based on industry and business-model similarity.

AMI Pharm Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Raziel Therapeutics
84%
Caliway Biopharmaceuticals
84%
Leios Therapeutics
83%

AMI Pharm Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquitySep 9, 2026
Series CFeb 25, 2026

AMI Pharm Co., Ltd. Investors

Notable investors and investment history

AMI Pharm Co., Ltd. investors
InvestorRounds
Hyundai Investment PartnersPrivate Equity
Dongwon Technology InvestmentPrivate Equity
Korea Investment PartnersSeries C
Hyundai Technology InvestmentPrivate Equity
Daishin SecuritiesPrivate Equity
NH Nonghyup BankPrivate Equity
Samho Green InvestmentPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 9, 2026

    $15.3M round from Hyundai Investment Partners and others.

  • Feb 25, 2026

    $5M round led by Industrial Bank of Korea and Korea Investment Partners.

AMI Pharm Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AMI Pharm Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMI Pharm Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Year Founded2005
Last FundingSep 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?